OptimizeRx (OPRX) Current Assets (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Current Assets data on file, last reported at $56.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 8.61% year-over-year to $56.2 million; the trailing twelve-month figure through Mar 2026 stood at $56.2 million (up 8.61% YoY), and the FY2025 full-year result was $64.7 million, up 19.91% from the prior year.
• Current Assets retreated to $56.2 million in Q1 2026, from $64.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $112.7 million in Q1 2022 to a low of $46.0 million in Q2 2024.
• A 5-year average of $71.9 million and a median of $56.3 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 49.57% in 2024 and rose 20.07% in 2025, its largest moves.
• Tracing OPRX's Current Assets over 5 years: stood at $98.6 million in 2022, then tumbled by 44.88% to $54.3 million in 2023, then decreased by 0.66% to $54.0 million in 2024, then rose by 19.91% to $64.7 million in 2025, then retreated by 13.21% to $56.2 million in 2026.
• Business Quant data shows OPRX's Current Assets at $56.2 million in Q1 2026, $64.7 million in Q4 2025, and $56.3 million in Q3 2025.